GB201604125D0 - Co-crystal - Google Patents
Co-crystalInfo
- Publication number
- GB201604125D0 GB201604125D0 GBGB1604125.3A GB201604125A GB201604125D0 GB 201604125 D0 GB201604125 D0 GB 201604125D0 GB 201604125 A GB201604125 A GB 201604125A GB 201604125 D0 GB201604125 D0 GB 201604125D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- crystal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000013078 crystal Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0069—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group
- C07J5/0076—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by a saturated or unsaturated hydrocarbon group by an alkyl group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1604125.3A GB201604125D0 (en) | 2016-03-10 | 2016-03-10 | Co-crystal |
PCT/EP2017/055489 WO2017153497A1 (en) | 2016-03-10 | 2017-03-08 | Increasing aqueous solubility of beclomethasone dipropionate by formation of co-crystals with co-crystal former |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1604125.3A GB201604125D0 (en) | 2016-03-10 | 2016-03-10 | Co-crystal |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201604125D0 true GB201604125D0 (en) | 2016-04-27 |
Family
ID=55952142
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1604125.3A Ceased GB201604125D0 (en) | 2016-03-10 | 2016-03-10 | Co-crystal |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB201604125D0 (en) |
WO (1) | WO2017153497A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2565803A (en) * | 2017-08-23 | 2019-02-27 | Univ Malta | Valacyclovir co-crystal |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07228525A (en) * | 1994-02-18 | 1995-08-29 | Pola Chem Ind Inc | External preparation for skin |
WO2008153945A2 (en) * | 2007-06-06 | 2008-12-18 | University Of South Florida | Nutraceutical co-crystal compositions |
EP2986634B1 (en) * | 2013-04-19 | 2019-11-20 | University of Houston System | Cocrystalline dhea formulations |
EP3080141A1 (en) * | 2013-12-12 | 2016-10-19 | Basf Se | Solid form of abiraterone acetate |
-
2016
- 2016-03-10 GB GBGB1604125.3A patent/GB201604125D0/en not_active Ceased
-
2017
- 2017-03-08 WO PCT/EP2017/055489 patent/WO2017153497A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2017153497A1 (en) | 2017-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL261175B (en) | Propyne-indole compounds | |
IL248991A0 (en) | Substituted dihydroisoquinolinone compounds | |
GB201602934D0 (en) | Compounds | |
SI3464336T1 (en) | Compounds | |
GB201604027D0 (en) | Compounds | |
GB201604020D0 (en) | Compounds | |
GB201610854D0 (en) | Compounds | |
GB201620119D0 (en) | Compounds | |
GB201619694D0 (en) | Compounds | |
IL263228A (en) | Benzoxaborole compounds | |
GB201608777D0 (en) | Compounds | |
GB201613946D0 (en) | Compounds | |
GB201604022D0 (en) | Compounds | |
GB201604030D0 (en) | Compounds | |
GB201621520D0 (en) | Compounds | |
GB201713217D0 (en) | Compounds | |
GB201622362D0 (en) | Compounds | |
GB201604029D0 (en) | Compounds | |
GB201604125D0 (en) | Co-crystal | |
GB201622365D0 (en) | Compounds | |
GB201604031D0 (en) | Compounds | |
GB201720511D0 (en) | Compounds | |
GB201622083D0 (en) | Compounds | |
GB201622072D0 (en) | Compounds | |
GB201621762D0 (en) | Herbicial Compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |